Skip to main content

Spectrum: Autism Research News

Tag: policy

August 2011

Jersey score

by  /  23 August 2011

New Jersey has the highest rates of autism in the U.S., but prevalence is highest in neighborhoods where annual incomes exceed $90,000.

Comments
May 2011

Hive mind

by  /  24 May 2011

Social media is powerful, and scientists can and should harness it to help answer difficult questions. But as with any easy solution, there is a corresponding cautionary tale: Social media can just as easily misguide as be meaningful.

Comments

Budget cuts hit autism research

by  /  13 May 2011

Cuts to the National Institutes of Health budget affect both investigators who have existing grants — which will receive one percent less than in 2010 — and those applying for funding.

Comments

Trendsetters

by  /  6 May 2011

Of 72 newly elected members of the National Academy of Sciences, 7 work either directly on autism or in related areas, illustrating the growing intellectual breadth and depth of the field.

Comments

Unequal rights

by  /  3 May 2011

Things are getting better for women in science, but we are still far from a world in which gender is irrelevant.

Comments
April 2011

To catch a thief

by  /  29 April 2011

A high-profile autism researcher has been indicted for stealing more than $1 million in autism research money.

Comments

Justice league

by  /  12 April 2011

Autism advocacy backed by science has fueled significant social change as an emphasis on the higher-functioning end of the spectrum lessens the stigma of the diagnosis.

Comments
March 2011

Face time

by  /  25 March 2011

In the world of Skype, instant messages and tweets, face-to-face interaction is still the best route to discovery, according to an intriguing study published in December.

Comments

Strategic update

by  /  4 March 2011

The Interagency Autism Coordinating Committee has released an updated list of priorities for government-funded autism research.

Comments
February 2011

Lost in translation

by  /  8 February 2011

The National Institutes of Health is adding a new $1 billion institute for early-stage drug development. But the agency’s plan to fund it by closing the National Center for Research Resources is causing some consternation.

Comments